These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 21391110

  • 1. Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats.
    Borde P, Mohan M, Kasture S.
    Nat Prod Res; 2011 Sep; 25(16):1549-59. PubMed ID: 21391110
    [Abstract] [Full Text] [Related]

  • 2. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
    Prahalathan P, Kumar S, Raja B.
    Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
    Silambarasan T, Raja B.
    Eur J Pharmacol; 2012 Mar 15; 679(1-3):81-9. PubMed ID: 22266490
    [Abstract] [Full Text] [Related]

  • 5. Effect of myricetin on blood pressure and metabolic alterations in fructose hypertensive rats.
    Godse S, Mohan M, Kasture V, Kasture S.
    Pharm Biol; 2010 May 15; 48(5):494-8. PubMed ID: 20645789
    [Abstract] [Full Text] [Related]

  • 6. Effect of pomegranate juice on Angiotensin II-induced hypertension in diabetic Wistar rats.
    Mohan M, Waghulde H, Kasture S.
    Phytother Res; 2010 Jun 15; 24 Suppl 2():S196-203. PubMed ID: 20020514
    [Abstract] [Full Text] [Related]

  • 7. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Callera GE, Tostes RC, Yogi A, Montezano AC, Touyz RM.
    Clin Sci (Lond); 2006 Feb 15; 110(2):243-53. PubMed ID: 16271043
    [Abstract] [Full Text] [Related]

  • 8. Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats.
    Galisteo M, García-Saura MF, Jiménez R, Villar IC, Zarzuelo A, Vargas F, Duarte J.
    Mol Cell Biochem; 2004 Apr 15; 259(1-2):91-9. PubMed ID: 15124912
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V, Wangensteen R, Sainz J, Duarte J, O'Valle F, Osuna A, Vargas F.
    Clin Sci (Lond); 2004 Mar 15; 106(3):251-9. PubMed ID: 14521506
    [Abstract] [Full Text] [Related]

  • 10. Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats.
    Safaeian L, Emami R, Hajhashemi V, Haghighatian Z.
    Biomed Pharmacother; 2018 Apr 15; 100():147-155. PubMed ID: 29428662
    [Abstract] [Full Text] [Related]

  • 11. Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats. Comparative study with verapamil.
    Galisteo M, García-Saura MF, Jiménez R, Villar IC, Wangensteen R, Zarzuelo A, Vargas F, Duarte J.
    Planta Med; 2004 Apr 15; 70(4):334-41. PubMed ID: 15095149
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive effect of 5-HT1A agonist buspirone and 5-HT2B antagonists in experimentally induced hypertension in rats.
    Shingala JR, Balaraman R.
    Pharmacology; 2005 Mar 15; 73(3):129-39. PubMed ID: 15539790
    [Abstract] [Full Text] [Related]

  • 13. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H, Yoshida M, Tojo C, Nakano A, Oshima Y, Kojima Y, Noda K, Wang J, Kobara M, Nakata T.
    Hypertens Res; 2011 Apr 15; 34(4):521-9. PubMed ID: 21270815
    [Abstract] [Full Text] [Related]

  • 14. Evolution of liver antioxidant status and iron implication during the development of deoxycorticosterone-saline hypertension in rats.
    Elhaïmeur F, Nicod L, Courderot-Masuyer C, Robin S, Guyon C, Bouhaddi M, Regnard J, Richert L, Berthelot A.
    Biol Trace Elem Res; 2005 Dec 15; 107(3):263-76. PubMed ID: 16286682
    [Abstract] [Full Text] [Related]

  • 15. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K, Nakata T, Kuwabara T, Itoh H, Yamahara Y, Takesako T, Tanabe S, Sasaki S, Asayama J, Nakagawa M.
    Blood Press Suppl; 1992 Dec 15; 3():48-52. PubMed ID: 1343289
    [Abstract] [Full Text] [Related]

  • 16. Effect of exercise training on liver antioxidant status of deoxycorticosterone acetate salt induced hypertensive rats.
    Elhaïmeur F, Courderot-Masuyer C, Nicod L, Bobillier-Chaumont S, Robin S, Richert L, Berthelot A.
    Can J Physiol Pharmacol; 2003 May 15; 81(5):469-75. PubMed ID: 12774853
    [Abstract] [Full Text] [Related]

  • 17. Modulatory effect of sesamol on DOCA-salt-induced oxidative stress in uninephrectomized hypertensive rats.
    Hemalatha G, Pugalendi KV, Saravanan R.
    Mol Cell Biochem; 2013 Jul 15; 379(1-2):255-65. PubMed ID: 23576423
    [Abstract] [Full Text] [Related]

  • 18. Cardioprotective potential of myricetin in isoproterenol-induced myocardial infarction in Wistar rats.
    Tiwari R, Mohan M, Kasture S, Maxia A, Ballero M.
    Phytother Res; 2009 Oct 15; 23(10):1361-6. PubMed ID: 19306480
    [Abstract] [Full Text] [Related]

  • 19. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
    Diaz J, Ni W, Thompson J, King A, Fink GD, Watts SW.
    J Pharmacol Exp Ther; 2008 Jun 15; 325(3):1031-8. PubMed ID: 18305011
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage.
    Seifi B, Kadkhodaee M, Karimian SM, Zahmatkesh M, Xu J, Soleimani M.
    Clin Exp Hypertens; 2010 Jan 15; 32(2):90-7. PubMed ID: 20374182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.